JVASX
Price
$40.04
Change
-$0.12 (-0.30%)
Updated
Oct 6 closing price
Net Assets
9.11B
VVIAX
Price
$73.08
Change
-$0.07 (-0.10%)
Updated
Oct 6 closing price
Net Assets
207.8B
Interact to see
Advertisement

JVASX vs VVIAX

Header iconJVASX vs VVIAX Comparison
Open Charts JVASX vs VVIAXBanner chart's image
JPMorgan Value Advantage I
Price$40.04
Change-$0.12 (-0.30%)
VolumeN/A
Net Assets9.11B
Vanguard Value Index Adm
Price$73.08
Change-$0.07 (-0.10%)
VolumeN/A
Net Assets207.8B
JVASX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
JVASX vs. VVIAX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVASX is a Hold and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. JVASX (9.11B). VVIAX pays higher dividends than JVASX: VVIAX (2.08) vs JVASX (1.37). JVASX was incepted earlier than VVIAX: JVASX (21 years) vs VVIAX (25 years). JVASX (0.84) is less costly to investors than VVIAX (0.05). JVASX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than JVASX: VVIAX (3000) vs JVASX (1000000). VVIAX annual gain was more profitable for investors over the last year : 7.50 vs. JVASX (-1.57). VVIAX return over 5 years is better than : 75.65 vs. JVASX (34.39).
JVASXVVIAXJVASX / VVIAX
Total Expense Ratio0.740.051,480%
Annual Report Gross Expense Ratio0.840.051,680%
Fund Existence21 years25 years-
Gain YTD6.92210.85264%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets9.11B208B4%
Annual Yield % from dividends1.372.0866%
Returns for 1 year-1.577.50-21%
Returns for 3 years17.4049.2335%
Returns for 5 years34.3975.6545%
Returns for 10 years54.61133.1441%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP0.710.07
+10.59%
GT Biopharma
ATYR0.820.05
+6.37%
aTyr Pharma Inc
BZ24.330.86
+3.66%
Kanzhun Limited
DXPE127.600.63
+0.50%
DXP Enterprises
TRC15.82-0.37
-2.29%
Tejon Ranch Co